Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Liu, Shuzhen

Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. [electronic resource] - JAMA oncology Nov 2017 - e172085 p. digital

Publication Type: Comparative Study; Journal Article

2374-2445

10.1001/jamaoncol.2017.2085 doi


Aged
Antineoplastic Agents, Immunological--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor--analysis
Breast Neoplasms--drug therapy
Clinical Trials, Phase III as Topic
Disease-Free Survival
Docetaxel
Female
Humans
Kaplan-Meier Estimate
Lapatinib
Lymphocytes, Tumor-Infiltrating--immunology
Middle Aged
Multicenter Studies as Topic
Multivariate Analysis
Neoplasm Metastasis
Paclitaxel--therapeutic use
Patient Selection
Predictive Value of Tests
Proportional Hazards Models
Prospective Studies
Protein Kinase Inhibitors--therapeutic use
Quinazolines--therapeutic use
Randomized Controlled Trials as Topic
Receptor, ErbB-2--analysis
Retrospective Studies
T-Lymphocytes, Cytotoxic--immunology
Taxoids--therapeutic use
Time Factors
Trastuzumab--therapeutic use
Treatment Outcome